Fig. 4From: Novel computational biology modeling system can accurately forecast response to neoadjuvant therapy in early breast cancerTumorScope Predict prognostic assessment. Graphs represent the probability of recurrence-free survival of patients that were clinically (left) evaluated for pCR (n = 27) or RD (n = 53) against TS predicted (right) pCR (n = 28) and RD (n = 52). TS predictions had similar prognostic value as clinical assessments. The zero-time point represents the date at which the patient had definitive surgery post-neoadjuvant treatment. Statistics were computed at 5-years post-surgeryBack to article page